Xalkori 250 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Y06
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,090
Award facts
- Contract value 100% obligated
- $16,089.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $16,089.62 to AmerisourceBergen Drug Corp for the supply of Xalkori 250 mg capsules (60-count units). This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by February 6, 2026. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle through December 2031 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare operations. The company's extensive federal portfolio encompasses brand-name and generic medications, specialty drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Xalkori, an oncology medication used in cancer treatment, exemplifies the company's role in supplying specialized pharmaceutical products essential to military treatment facilities and other federal healthcare institutions through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9Y06?
SPE2DR26F9Y06 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9Y06 worth?
The government has obligated $16,090 on SPE2DR26F9Y06.
Is contract SPE2DR26F9Y06 an order under another contract?
Yes. SPE2DR26F9Y06 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Y06 competed?
The extent of competition for SPE2DR26F9Y06 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award